OR

Browse By

Cannabidiol (CBD) for Clozapine Refractory Schizophrenia (CanCloz) (2023–2024)

Grant type:
University of Sydney
Researchers:

  • Professor Dan Siskind

    Adjunct Professor
    Queensland Brain Institute
    NHMRC Emerging Lead Fellow (Second)
    Princess Alexandra Hospital Southside Clinical Unit
    Faculty of Medicine
Funded by:
The University of Sydney